Co-transformation by human papillomavirus types 6 and 11 - PubMed (original) (raw)
Co-transformation by human papillomavirus types 6 and 11
A Storey et al. J Gen Virol. 1990 Jan.
Abstract
Human papillomavirus (HPV) types 6 and 11 are usually found in benign genital lesions and laryngeal papillomas. However, the occasional occurrence of their DNAs in carcinomas of the genital tract and larynx suggests that they have some tumorigenic activity. In this paper, we have examined the cotransforming and transactivation activities of the E7 genes from these virus types and show that they cooperate with ras to transform primary cells, but at a greatly reduced level compared to HPV-16 E7. Although the efficiencies of transformation in vitro by HPV-6 and HPV-11 are low, it is striking that the cells that are transformed are highly tumorigenic in vivo in immunocompetent animals. Transactivation studies using the adenovirus E2 promoter demonstrated that both HPV-11 E7 and HPV-16 E7 could stimulate transcription to a similar degree. These results separate the transactivation and co-transforming activities of HPV E7 genes.
Similar articles
- Transformation of primary BRK cells by human papillomavirus type 16 and EJ-ras is increased by overexpression of the viral E2 protein.
Lees E, Osborn K, Banks L, Crawford L. Lees E, et al. J Gen Virol. 1990 Jan;71 ( Pt 1):183-93. doi: 10.1099/0022-1317-71-1-183. J Gen Virol. 1990. PMID: 2154535 - Mutations of the human papillomavirus type 16 E7 gene that affect transformation, transactivation and phosphorylation by the E7 protein.
Storey A, Almond N, Osborn K, Crawford L. Storey A, et al. J Gen Virol. 1990 Apr;71 ( Pt 4):965-70. doi: 10.1099/0022-1317-71-4-965. J Gen Virol. 1990. PMID: 2157805 - Relative enhancer activity and transforming potential of authentic human papillomavirus type 6 genomes from benign and malignant lesions.
Farr A, Wang H, Kasher MS, Roman A. Farr A, et al. J Gen Virol. 1991 Mar;72 ( Pt 3):519-26. doi: 10.1099/0022-1317-72-3-519. J Gen Virol. 1991. PMID: 1848589 - The cell biology of human papillomavirus transformed cells.
Matlashewski G. Matlashewski G. Anticancer Res. 1989 Sep-Oct;9(5):1447-56. Anticancer Res. 1989. PMID: 2556072 Review. - Cellular and molecular alterations in human epithelial cells transformed by recombinant human papillomavirus DNA.
DiPaolo JA, Popescu NC, Alvarez L, Woodworth CD. DiPaolo JA, et al. Crit Rev Oncog. 1993;4(4):337-60. Crit Rev Oncog. 1993. PMID: 8394744 Review.
Cited by
- The papillomavirus E7 proteins.
Roman A, Munger K. Roman A, et al. Virology. 2013 Oct;445(1-2):138-68. doi: 10.1016/j.virol.2013.04.013. Epub 2013 May 31. Virology. 2013. PMID: 23731972 Free PMC article. Review. - Papillomavirus E7 protein binding to the retinoblastoma protein is not required for viral induction of warts.
Defeo-Jones D, Vuocolo GA, Haskell KM, Hanobik MG, Kiefer DM, McAvoy EM, Ivey-Hoyle M, Brandsma JL, Oliff A, Jones RE. Defeo-Jones D, et al. J Virol. 1993 Feb;67(2):716-25. doi: 10.1128/JVI.67.2.716-725.1993. J Virol. 1993. PMID: 8380462 Free PMC article. - Single amino acid substitutions in "low-risk" human papillomavirus (HPV) type 6 E7 protein enhance features characteristic of the "high-risk" HPV E7 oncoproteins.
Sang BC, Barbosa MS. Sang BC, et al. Proc Natl Acad Sci U S A. 1992 Sep 1;89(17):8063-7. doi: 10.1073/pnas.89.17.8063. Proc Natl Acad Sci U S A. 1992. PMID: 1325643 Free PMC article. - Rhesus papillomavirus type 1 cooperates with activated ras in transforming primary epithelial rat cells independent of dexamethasone.
Schneider JF, McGlennen RC, LaBresh KV, Ostrow RS, Faras AJ. Schneider JF, et al. J Virol. 1991 Jun;65(6):3354-8. doi: 10.1128/JVI.65.6.3354-3358.1991. J Virol. 1991. PMID: 1851883 Free PMC article. - The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.
Efird JT, Toland AE, Lea CS, Phillips CJ. Efird JT, et al. Clin Med Insights Oncol. 2011 Mar 27;5:55-75. doi: 10.4137/CMO.S6905. Clin Med Insights Oncol. 2011. PMID: 21499554 Free PMC article.